The development of insulin resistance with high fat feeding in rats does not involve either decreased insulin receptor tyrosine kinase activity or membrane glycoprotein PC-1

Biochemical and Molecular Medicine

Volumn 59, Issue 2, 1996, Pages 174-181

  Özel, Begüm ^a   Youngren, Jack F ^b   Kim, Jason K ^a   Goldfine, Ira D ^b   Sung, Chin K ^a   Youn, Jang H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; MEMBRANE PROTEIN; NUCLEOTIDE PYROPHOSPHATASE; PHOSPHODIESTERASE I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; ENZYME ACTIVITY; FAT INTAKE; GLUCOSE TRANSPORT; INSULIN RESISTANCE; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; RAT; SKELETAL MUSCLE;

EID: 0030478948     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.0084     Document Type: Article

References (37)

1. 1. Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM. Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J Clin Inv 68:957-969, 1981.
2. 2. DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: A common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313-319, 1982.
3. 3. Hollenbeck CB, Chen YI, Reaven GM. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization. Diabetes 33:622-626, 1984.
4. 4. Reaven GM. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
5. 5. Kahn CR. Causes of insulin resistance. Nature 373:384-385, 1995.
6. 6. Caro JF, Ittoop O, Pories WM, Meelheim D, Flickinger EG, Thomas F, Jenguin MJ, Silverman JF, Khazania PG, Sinha MK. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. J Clin Inv 78:249-258, 1986.
7. 7. Fredenberg GR, Henry RR, Klein HH, Reichardt DR, Olefsky JM. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Inv 79:240-250, 1987.
8. 8. Arner P, Pollare T, Lithell H, Livingston JN. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:437-440, 1987.
9. 9. Sbraccia P, Goodman PA, Maddux BA, Wong KY, Chen Y-DI, Reaven GM, Goldfine ID. Production of an inhibitor of insulin receptor tyrosine kinase in fibroblasts from a patient with insulin resistance and NIDDM. Diabetes 40:295-299, 1991.
10. 10. Maddux BA, Sbraccia P, Reaven GM, Moller DE, Goldfine ID. Inhibitors of insulin receptor tyrosine kinase in fibroblasts from diverse patients with impaired insulin action: Evidence for a novel mechanism of postreceptor insulin resistance. J Clin Endocrinol Metab 77:73-79, 1993.
11. 11. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, Reaven GM, Goldfine ID. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373:448-451, 1995.
12. 12. Frittitta L, Youngren JF, Vigneri R, Maddux BA, Trischitta V, Goldfine ID. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: Relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia 39:1190-1195, 1996.
13. 13. Youngren JF, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm GL, Goldfine ID. Skeletal muscle content of membrane glycoprotein PC-1 in obesity: relationship to muscle glucose transport. Diabetes 45:1324-1328, 1996.
14. 14. Grundleger ML, Thenen SW. Decreased insulin binding, glucose transport, and glucose metabolism in soleus muscle of rats fed a high fat diet. Diabetes 31:232-237, 1982.
15. 15. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 251:E576-E583, 1986.
16. 16. Kim JK, Wi JK, Youn JH. Metabolic impairment precedes insulin resistance in skeletal muscle during high fat feeding in rats. Diabetes 45:651-658, 1996.
17. 17. Buchanan TA, Fisler JS, Underberger S, Sipos GF, Bray GA. Whole body insulin sensitivity in Osborne-Mendel and S 5B/P1 rats eating a low-or high-fat diet. Am J Physiol 263:R785-R789, 1992.
18. 18. Youn JH, Buchanan TA. Fasting does not impair insulin-stimulated glucose uptake but alters intracellular glucose metabolism in conscious rats. Diabetes 42:757-763, 1993.
19. 19. Ohshima K, Shargill NS, Chan TM, Bray GA. Adrenalectomy reverses insulin resistance in muscle from obese (ob/ ob) mice. Am J Physiol 246:E193-E197, 1984.
20. 20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
21. 21. Miralles F, Takeda Y, Escribano MJ. Comparison of carbohydrate and peptide biotinylation on the immunological activity of IgG1 murine monoclonal antibodies. J Immunol Methods 140:191-196, 1991.
22. 22. Boge A, Roth RA. A nonradioactive assay for the insulin receptor tyrosine kinase: use in monitoring receptor kinase activity after activation of overexpressed protein kinase C alpha and high glucose treatment. Anal Biochem 231:323-332, 1995.
23. 23. Rebbe NF, Tong BD, Hickman S. Expression of nucleotide pyrophosphatase and alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. Mol Immunol 30:87-93, 1993.
24. 24. Razzel WE, Khorana HG. Studies on polynucleotides. III. Enzymic degradation. Substrate specificity and properties of snake venom phosphodiesterase. J Biol Chem 234:2105-2113, 1959.
25. 25. Olefsky JM, Kolterman OG. Mechanisms of insulin resistance in obesity and noninsulin-dependent (Type II) diabetes. Am J Med 70:151-168, 1981.
26. 26. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity: Evidence for receptor and postreceptor defects. J Clin Inv 65:1272-1284, 1980.
27. 27. Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350, 1987.
28. 28. Hamman RF. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diab Metab Rev 8:287-338, 1992.
29. 29. O'Dea K. Obesity and diabetes in "the land of milk and honey." Diab Metab Rev 8:373-388, 1992.
30. 30. Takahashi T, Old LJ, Boyse EA. Surface alloantigens of plasma cells. J Exp Med 131:1325-1341, 1970.
31. 31. Harahap AR, Goding JW. Distribution of the murine plasma cell antigen PC-1 in non-lymphoid tissues. J Immunol 141:2317-2320, 1988.
32. 32. Belli SI, Goding JW. Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities. Eur J Biochem 226:433-443, 1994.
33. 33. Funakoshi I, Kato H, Horie K, Yano Y, Kobayashi H, Inoue T, Suzuki H, Fukui S, Tsukahara M, Kajii T, Yamashina I. Molecular cloning of cDNAs for human fibroblast nucleotide pyrophosphatase. Arch Biochem Biophys 295:180-187, 1992.
34. 34. Boyd JJ, Contreras I, Kern M, Tapscott EB, Downes DL, Frisell WR, Dohm GL. Effect of a high-fat-sucrose diet on in vivo insulin receptor kinase activation. Am J Physiol 259:E111-E116, 1990.
35. 35. Watarai T, Kobayashi M, Takata Y, Sasaoka T, Iwasaki M, Shigeta Y. Alteration of insulin-receptor kinase activity by high fat feeding. Diabetes 37:1397-1404, 1988.
36. 36. Kim Y, Tamura T, Iwashita S, Tokuyama K, Suzuki M. Effect of high-fat diet on gene expression of GLUT4 and insulin receptor in soleus muscle. Biochim Biophys Res Commun 202:519-526, 1994.
37. 37. Stevenson RW, McPherson RK, Persson LM, Genereux PE, Swick AG, Spitzer J, Herbst JJ, Andrews KM, Kreutter DK, Gibbs EM. The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high fat diet. Diabetes 45:60-66, 1996.